Joint Position Paper on the Hospital Exemption Scheme for ATMPs
13.07.23
Joint Position Paper on the Hospital Exemption Scheme for ATMPs
Our organisations are committed to engage with policymakers and interested stakeholders for an inclusive and solutions-driven approach on the HE in the best interest of patients across the EU.
In the context of the revision of the EU General Pharmaceutical Legislation, this paper puts forward joint recommendations from ARM (Alliance for Regenerative Medicine), EFPIA, EuropaBio, EUCOPE (European Confederation of Pharmaceutical Entrepreneurs) and ISCT (International Society for Cell & Gene Therapy), for the reform of the Hospital Exemption (HE) scheme for Advanced Therapy Medicinal Products (ATMPs).
Read more here.